FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to compounds of formula 
, where R1 represents L1C(O)OT; R2 represents C1-C10alkyl; n is equal 0; R4 and R5 independently represent H; L1 represents bond; T represents ethyl, propyl, isobutyl, n-butyl; and its pharmaceutically acceptable salts, stereoisomeric mixtures and enanthiomers.
EFFECT: compounds provide anaesthetic action in mammals.
8 cl, 8 dwg, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ETOMIDATE ANALOGUES WITH IMPROVED PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES | 2009 |
|
RU2540116C2 |
| STEROID COMPOUND FOR USE IN TREATMENT OF HEPATIC ENCEPHALOPATHY | 2015 |
|
RU2684616C2 |
| THERAPEUTIC COMPOUNDS | 2008 |
|
RU2470907C2 |
| THERAPEUTIC COMPOUNDS | 2008 |
|
RU2470908C2 |
| SPECIFIC DIARYLHYDANTOIN AND DIARYLTHIODIARYL COMPOUNDS | 2010 |
|
RU2548918C2 |
| DERIVATIVE OF PYRROLIDINE ACETAMIDE OR ITS COMBINATION FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | 2000 |
|
RU2261093C2 |
| CB1 RECEPTOR ANTAGONISTS | 2012 |
|
RU2593751C2 |
| (N-SUBSTITUTED IMIDAZOLE)-CARBOXYLIC ESTER CHIRAL COMPOUND CONTAINING ETHER SIDE CHAIN, PREPARATION METHOD AND APPLICATION | 2014 |
|
RU2659784C2 |
| USE OF GABA-RECEPTOR MODULATORS FOR TREATMENT OF ITCH | 2017 |
|
RU2781636C2 |
| CELASTROL AND DERIVATIVES THEREOF FOR TREATING OBESITY | 2015 |
|
RU2706239C2 |
